ArticleCureus2024
Placental Adhesion Subsequent to Uterine Preservation via Resuscitative Endovascular Balloon Occlusion of the Aorta: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An adherent placenta is a life-threatening condition that impairs the mother's life owing to hemorrhagic shock and disseminated intravascular coagulation. Profound hemorrhage resulting from placental abruption is often managed using hysterectomy to preserve the mother's life, although the consequent loss of fertility can be devastating, particularly in younger women. Thus, strategies that facilitate fertility preservation while effectively controlling hemorrhage should be considered viable alternatives. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is commonly performed in patients experiencing traumatic hemorrhagic shock; however, its application in obstetric cases remains infrequent. Herein, we report a case in which REBOA was used to control hemorrhage following the manual removal of an adherent placenta, with the aim of preserving the uterus. A 28-year-old woman presented to our hospital with hemorrhagic shock owing to extensive bleeding from an adherent placenta. As the patient was a young, primiparous woman with a strong desire to preserve her uterus, we opted for manual placental removal. However, manual removal poses a risk of exacerbating the hemorrhage. Therefore, REBOA was performed by emergency physicians to reduce bleeding during placental abruption, and intrauterine balloon tamponade was used to achieve hemostasis without compromising the patient's condition. The use of REBOA in the management of placenta accreta not only improves survival rates but may also provide crucial time for fertility-preserving interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.